Literature DB >> 20520858

Mass-spectrometry-based clinical proteomics--a review and prospective.

Carol E Parker1, Terry W Pearson, N Leigh Anderson, Christoph H Borchers.   

Abstract

This review reports on the current and emerging technologies for the use of mass-spectrometry-based proteomics in clinical applications.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20520858      PMCID： PMC2966304          DOI： 10.1039/c0an00105h

Source DB:  PubMed          Journal:  Analyst        ISSN： 0003-2654            Impact factor:   4.616


  87 in total

1.  Biomarker qualification pilot process at the US Food and Drug Administration.

Authors:  Federico Goodsaid; Felix Frueh
Journal:  AAPS J       Date:  2007-03-23       Impact factor: 4.009

Review 2.  Serum protein profiling by solid phase extraction and mass spectrometry: a future diagnostics tool?

Authors:  Anne K Callesen; Jonna S Madsen; Werner Vach; Torben A Kruse; Ole Mogensen; Ole N Jensen
Journal:  Proteomics       Date:  2009-03       Impact factor: 3.984

3.  Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma.

Authors:  Michael A Kuzyk; Derek Smith; Juncong Yang; Tyra J Cross; Angela M Jackson; Darryl B Hardie; N Leigh Anderson; Christoph H Borchers
Journal:  Mol Cell Proteomics       Date:  2009-05-01       Impact factor: 5.911

Review 4.  A human proteome detection and quantitation project.

Authors:  N Leigh Anderson; Norman G Anderson; Terry W Pearson; Christoph H Borchers; Amanda G Paulovich; Scott D Patterson; Michael Gillette; Ruedi Aebersold; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2009-01-07       Impact factor: 5.911

5.  Performance of a matrix-assisted laser desorption ionization-time-of-flight mass spectrometry system for the identification of bacterial isolates in the clinical routine laboratory.

Authors:  Ulrich Eigner; Martin Holfelder; Klaus Oberdorfer; Ulrike Betz-Wild; Daniela Bertsch; Anne-Marie Fahr
Journal:  Clin Lab       Date:  2009       Impact factor: 1.138

6.  High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories.

Authors:  S Q van Veen; E C J Claas; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2010-01-06       Impact factor: 5.948

7.  Mass spectrometric immunoassay.

Authors:  R W Nelson; J R Krone; A L Bieber; P Williams
Journal:  Anal Chem       Date:  1995-04-01       Impact factor: 6.986

8.  A quick and easy method to identify bacteria by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.

Authors:  Xaviera Pennanec; Alain Dufour; Dominique Haras; Karine Réhel
Journal:  Rapid Commun Mass Spectrom       Date:  2010-02       Impact factor: 2.419

9.  Carbon nanotubes as assisted matrix for laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Songyun Xu; Yongfeng Li; Hanfa Zou; Jieshan Qiu; Zhong Guo; Baochuan Guo
Journal:  Anal Chem       Date:  2003-11-15       Impact factor: 6.986

10.  Advancement of biomarker discovery and validation through the HUPO plasma proteome project.

Authors:  Gilbert S Omenn
Journal:  Dis Markers       Date:  2004       Impact factor: 3.434
View more
  27 in total

1.  Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics.

Authors:  Amelia C Peterson; Jason D Russell; Derek J Bailey; Michael S Westphall; Joshua J Coon
Journal:  Mol Cell Proteomics       Date:  2012-08-03       Impact factor: 5.911

Review 2.  Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.

Authors:  Carol E Parker; Christoph H Borchers
Journal:  Mol Oncol       Date:  2014-03-20       Impact factor: 6.603

Review 3.  Review, evaluation, and discussion of the challenges of missing value imputation for mass spectrometry-based label-free global proteomics.

Authors:  Bobbie-Jo M Webb-Robertson; Holli K Wiberg; Melissa M Matzke; Joseph N Brown; Jing Wang; Jason E McDermott; Richard D Smith; Karin D Rodland; Thomas O Metz; Joel G Pounds; Katrina M Waters
Journal:  J Proteome Res       Date:  2015-04-22       Impact factor: 4.466

Review 4.  Proteomic analysis in multiple myeloma research.

Authors:  Jana Cumova; Anna Potacova; Zbynek Zdrahal; Roman Hajek
Journal:  Mol Biotechnol       Date:  2011-01       Impact factor: 2.695

5.  Peptide and Protein Quantification Using Automated Immuno-MALDI (iMALDI).

Authors:  Huiyan Li; Robert Popp; Bjorn Frohlich; Michael X Chen; Christoph H Borchers
Journal:  J Vis Exp       Date:  2017-08-18       Impact factor: 1.355

Review 6.  Peptide immunoaffinity enrichment coupled with mass spectrometry for peptide and protein quantification.

Authors:  Jeffrey R Whiteaker; Amanda G Paulovich
Journal:  Clin Lab Med       Date:  2011-09       Impact factor: 1.935

Review 7.  Urine biomarkers for necrotizing enterocolitis.

Authors:  Karl G Sylvester; R Lawrence Moss
Journal:  Pediatr Surg Int       Date:  2015-03-26       Impact factor: 1.827

Review 8.  Bioanalytical chemistry of cytokines--a review.

Authors:  Julie A Stenken; Andreas J Poschenrieder
Journal:  Anal Chim Acta       Date:  2014-10-12       Impact factor: 6.558

Review 9.  Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetes.

Authors:  Hussein Yassine; Chad R Borges; Matthew R Schaab; Dean Billheimer; Craig Stump; Peter Reaven; Serrine S Lau; Randall Nelson
Journal:  Proteomics Clin Appl       Date:  2013-07-09       Impact factor: 3.494

Review 10.  Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics.

Authors:  Tujin Shi; Dian Su; Tao Liu; Keqi Tang; David G Camp; Wei-Jun Qian; Richard D Smith
Journal:  Proteomics       Date:  2012-04       Impact factor: 3.984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.